<!--Article Start-->
<html>
 <head>
  <link rel="stylesheet" type="text/css" href="../../../../styles.css">
 </head>
 <body>
  <h1>The Trust in Pharma: Why China and India Outpace Europe and the US</h1> <img src="images/The-Trust-in-Pharma-Why-China-and-India-Outpace-Europe-and-the-US.jpeg" alt="+The-Trust-in-Pharma-Why-China-and-India-Outpace-Europe-and-the-US+">
  <p>In recent times, trust in pharmaceutical companies has fluctuated, with citizens around the world weighing in on the industry's reliability. However, Edelman's Trust Barometer has revealed that China and India, both considered emerging economies, trust pharmaceutical companies the most, while Europe and the US lag behind.</p>
  <p>While this may come as a surprise to some, it's not a new trend. In fact, the trust gap between developed and developing nations has been widening for decades. In light of this study, here's a deeper dive on why China and India are leading the charge and what others can learn from them.</p>
  <h2>An Exciting Story</h2>
  <p>One particular story encapsulates why China and India have come to trust their pharmaceutical companies more than their neighbors. The COVID-19 pandemic has catalyzed the production of vaccines to fight the virus, and two vaccines have been made available under emergency-use authorization: Covaxin and Covishield. Both vaccines are in use in India and have proven to be effective.</p>
  <p>In contrast, Pfizer and Moderna, two US manufacturers, are facing skepticism due to concerns over the safety of their vaccines. European nations are struggling with vaccine rollouts due to supply chain issues. Meanwhile, China is exporting vaccines to its global partners, building the trust and confidence that its neighbors need. This fact is rooted in the history of China's pharmaceutical industry; the country has become a hub for generic drug manufacturing, earning it a reputation as an affordable and reliable manufacturer of pharmaceuticals.</p>
  
  <p>The trust in China and India's pharmaceutical industry is not unfounded. For instance:</p>
  <ul>
   <li>India is the world's largest manufacturer of generic drugs, with more than 18% of the global market share.</li>
   <li>China's market share is comparatively smaller, but they have a significant competitive edge in manufacturing.</li>
   <li>In the 1980s, India began regulating its pharmaceutical industry, with a focus on quality over quantity.</li>
   <li>From the 1990s through the 2000s, the country established itself as a reliable exporter of high-quality generic drugs.</li>
   <li>Since then, India has made strides in pharmaceutical research, producing breakthrough drugs for the treatment of cancer, tuberculosis, and hepatitis C.</li>
  </ul>
  <h2>An Eye-Catching Headline</h2>
  <p>Why China and India Trust Pharma more than the US and Europe</p>
  <h2></h2>
  <ol>
   <li>Developed countries should strive to strike a balance between price control and innovation to catch up with developing nations that have prioritized affordability over profitability.</li>
   <li>As the pandemic rages on, delivering vaccines to the global population will require cooperation between developed and developing nations' pharmaceutical manufacturers and regulatory bodies.</li>
   <li>Trust can be earned through transparency, quality control, and sustained delivery of excellent products.</li>
  </ol>
  <h2> and Case Studies</h2>
  <p>Pharma companies around the world would do well to observe India's example. For instance, in January 2013, the Indian Patent Office rejected Gilead Science's patent for Sovaldi, an antiviral drug used to treat Hepatitis C. As a result, Indian manufacturers were free to produce lower-priced generic equivalents of the drug, bringing treatments within reach of poorer populations. The move ended up saving hundreds of thousands of lives.</p>
  <p>This ruling shows that India prioritizes serving its citizens over the profits of multinationals, resulting in increased trust from its citizens. Additionally, India has been increasing its investment in the drug discovery process, much of which is conducted by clinical research organizations that have accumulated massive amounts of data. The data on diseases specific to India has the potential to drive drug discovery for developing nations and generate funds for health research.</p>
  <h2>Practical Tips</h2>
  <p>In conclusion, here are some practical tips for pharmaceutical companies around the world that are looking to gain or regain trust:</p>
  <ul>
   <li>Transparency is key. This includes facilitating access to clinical trials data and other information that can help patients make informed decisions.</li>
   <li>Quality control is important, especially in developing markets where counterfeit and counterfeit drugs are prevalent.</li>
   <li>Don't forget about investing in R&amp;D while balancing affordability as well as quality.</li>
  </ul>
  <h2>References and Hashtags</h2>
  <h4>References:</h4>
  <ul>
   <li>https://www.edelman.com/trust/2021-trust-barometer</li>
   <li>https://pharmacentre.in/2018/08/16/why-does-the-world-depend-on-india-for-generic-drugs/</li>
   <li>https://www.statista.com/topics/1670/pharmaceutical-industry-in-india/</li>
   <li>https://www2.deloitte.com/content/dam/Deloitte/in/Documents/life-sciences-health-care/in-lshc-indian-pharmaceutical-industry-noexp.pdf</li>
  </ul>
  <h4>Hashtags:</h4>
  <ul>
   <li>#Pharma</li>
   <li>#India</li>
   <li>#China</li>
   <li>#TrustinPharma</li>
   <li>#AffordableHealthcare</li>
  </ul>
  <h4>Article Category:</h4>
  <p>Pharmaceutical Industry and Healthcare</p><!--Article End-->
 <section id=social>
<h2>Curated by Team Akash.Mittal.Blog  </h2>
<p>
  <a href="https://twitter.com/intent/tweet?url=https://akash.mittal.blog/The-Trust-in-Pharma-Why-China-and-India-Outpace-Europe-and-the-US.html" target="_blank">
  <i class="fa fa-twitter"></i> Share on Twitter
</a>
</br>
<a href="https://www.linkedin.com/shareArticle?url=https://akash.mittal.blog/The-Trust-in-Pharma-Why-China-and-India-Outpace-Europe-and-the-US.html" target="_blank">
  <i class="fa fa-linkedin"></i> Share on LinkedIn
</a>
</p>
</section>
</body>
</html>